Firazyr 10 mg (Icatibant (Icatibant Acetate) SOLUTION) 10 MG

Firazyr 10 mg is a subcutaneous solution containing icatibant, used for managing hereditary angioedema attacks. This medication helps reduce swelling and discomfort associated with the condition.

Strength

10 MG

Pack Size

3ML

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Firazyr 10 mg is primarily used for the treatment of acute attacks of hereditary angioedema (HAE) in adults. HAE is a rare genetic disorder that causes swelling in various parts of the body. This medication works by blocking the effects of a substance in the body that causes inflammation and swelling. People often ask, 'What is Firazyr used for?' and the answer is that it is specifically designed to provide rapid relief during HAE attacks.

Side Effects

Common effects of Firazyr 10 mg may include redness, warmth, or itching at the injection site. Some users might experience dizziness or nausea. These effects are generally mild and temporary. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Firazyr 10 mg should be used with caution in individuals with known allergies to icatibant or any of its components. It is important to follow the prescribed dosage and administration instructions. Keep the medication out of reach of children and store it as directed.

Avoid Interactions

Firazyr 10 mg may interact with other medications, including those that affect the immune system or blood pressure. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.

Frequently Asked Questions

Firazyr 10 mg is used to treat acute attacks of hereditary angioedema (HAE) in adults.

Firazyr 10 mg is administered as a subcutaneous injection.

Common side effects may include redness, warmth, or itching at the injection site, dizziness, and nausea.

Firazyr 10 mg is specifically indicated for use in adults. Consult a healthcare provider for advice on pediatric use.

Firazyr 10 mg should be stored according to the instructions provided with the medication, typically at room temperature.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.